Detalhe da pesquisa
1.
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants.
N Engl J Med
; 386(9): 837-846, 2022 03 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35235726
2.
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.
N Engl J Med
; 383(5): 415-425, 2020 07 30.
Artigo
Inglês
| MEDLINE | ID: mdl-32726528
3.
Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity.
N Engl J Med
; 386(9): 892-894, 2022 03 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35235733
4.
Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort.
Respir Res
; 21(1): 77, 2020 Mar 30.
Artigo
Inglês
| MEDLINE | ID: mdl-32228581
5.
Safety, Tolerability, and Pharmacokinetics of MEDI8897, the Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody with an Extended Half-Life, in Healthy Adults.
Antimicrob Agents Chemother
; 61(3)2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27956428
6.
A novel investigational Fc-modified humanized monoclonal antibody, motavizumab-YTE, has an extended half-life in healthy adults.
Antimicrob Agents Chemother
; 57(12): 6147-53, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-24080653
7.
Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials.
Lancet Child Adolesc Health
; 7(3): 180-189, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36634694
8.
A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease.
Pediatr Res
; 70(2): 186-91, 2011 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-21522037
9.
A phase 2, randomized, double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab and palivizumab administered in the same season.
BMC Pediatr
; 10: 38, 2010 Jun 03.
Artigo
Inglês
| MEDLINE | ID: mdl-20525274
10.
Safety, Tolerability and Pharmacokinetics of MEDI8897, an Extended Half-life Single-dose Respiratory Syncytial Virus Prefusion F-targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants.
Pediatr Infect Dis J
; 37(9): 886-892, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29373476
11.
Passive and active immunization against respiratory syncytial virus for the young and old.
Expert Rev Vaccines
; 16(7): 1-13, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28525961
12.
Heart rate characteristics monitoring for neonatal sepsis.
IEEE Trans Biomed Eng
; 53(1): 126-32, 2006 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-16402612
13.
Toward quantitative fetal heart rate monitoring.
IEEE Trans Biomed Eng
; 53(1): 111-8, 2006 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-16402610
14.
Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial.
Lancet Infect Dis
; 15(12): 1398-408, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26511956
15.
Motavizumab treatment of infants hospitalized with respiratory syncytial virus infection does not decrease viral load or severity of illness.
Pediatr Infect Dis J
; 33(7): 703-9, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24356256
16.
Nearest-neighbor and logistic regression analyses of clinical and heart rate characteristics in the early diagnosis of neonatal sepsis.
Med Decis Making
; 30(2): 258-66, 2010.
Artigo
Inglês
| MEDLINE | ID: mdl-19541797
17.
Heart rate characteristics and clinical signs in neonatal sepsis.
Pediatr Res
; 61(2): 222-7, 2007 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-17237726
18.
Papaverine prolongs patency of peripheral arterial catheters in neonates.
J Pediatr
; 146(1): 62-5, 2005 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-15644824
19.
Heart rate characteristics and laboratory tests in neonatal sepsis.
Pediatrics
; 115(4): 937-41, 2005 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-15805367
20.
Heart rate characteristics: novel physiomarkers to predict neonatal infection and death.
Pediatrics
; 116(5): 1070-4, 2005 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-16263991